Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Global convergence of COVID-19 basic reproduction number and estimation from early-time SIR dynamics

View ORCID ProfileGabriel G. Katul, View ORCID ProfileAssaad Mrad, View ORCID ProfileSara Bonetti, View ORCID ProfileGabriele Manoli, View ORCID ProfileAnthony J. Parolari
doi: https://doi.org/10.1101/2020.04.10.20060954
Gabriel G. Katul
1Nicholas School of the Environment, Box 80328, Duke University, Durham, NC 27708, USA
2Department of Civil and Environmental Engineering, Duke University, Durham, NC 27708, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gabriel G. Katul
  • For correspondence: gaby@duke.edu
Assaad Mrad
1Nicholas School of the Environment, Box 80328, Duke University, Durham, NC 27708, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Assaad Mrad
Sara Bonetti
3Department of Environmental Systems Science, ETH Zürich, 8092 Zürich, Switzerland
4Bartlett School of Environment, Energy and Resources, University College London, WC1H 0NN London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sara Bonetti
Gabriele Manoli
5Department of Civil, Environmental and Geomatic Engineering, University College London, London, WC1E 6BT, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gabriele Manoli
Anthony J. Parolari
6Department of Civil, Construction, and Environmental Engineering, Marquette University, Milwaukee, WI 53233, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anthony J. Parolari
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The SIR (‘susceptible-infectious-recovered’) formulation is used to uncover the generic spread mechanisms observed by COVID-19 dynamics globally, especially in the early phases of infectious spread. During this early period, potential controls were not effectively put in place or enforced in many countries. Hence, the early phases of COVID-19 spread in countries where controls were weak offer a unique perspective on the ensemble-behavior of COVID-19 basic reproduction number Ro. The work here shows that there is global convergence (i.e. across many nations) to an uncontrolled Ro = 4.5 that describes the early time spread of COVID-19. This value is in agreement with independent estimates from other sources reviewed here and adds to the growing consensus that the early estimate of Ro = 2.2 adopted by the World Health Organization is low. A reconciliation between power-law and exponential growth predictions is also featured within the confines of the SIR formulation. Implications for evaluating potential control strategies from this uncontrolled Ro are briefly discussed in the context of the maximum possible infected fraction of the population (needed for assessing health care capacity) and mortality (especially in the USA given diverging projections). Model results indicate that if intervention measures still result in Ro > 2.7 within 49 days after first infection, intervention is unlikely to be effective in general for COVID-19. Current optimistic projections place mortality figures in the USA in the range of 100,000 fatalities. For fatalities to be confined to 100,000 requires a reduction in Ro from 4.5 to 2.7 within 17 days of first infection assuming a mortality rate of 3.4%.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding received

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Daily confirmed COVID-19 infections in World countries are available at https://www.ecdc.europa.eu/en/publications-data/download-todays-data-geographic-distribution-covid-19-cases-worldwide (accessed on 08/04/2020). The dataset includes population estimates for each country as obtained from the 2018 United Nations census. Reported cases for UTLAs in the UK and provinces in Italy were obtained from https://www.gov.uk/government/publications/covid-19-track-coronavirus-cases (accessed on 09/04/2020) and https://github.com/pcm-dpc/COVID-19 (accessed on 09/04/2020), respectively. Population counts for UTLAs and Italian provinces are available at https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/datasets/populationestimatesforukenglandandwalesscotlandandnorthernireland (accessed on 04/04/2020) and http://dati.istat.it/Index.aspx?DataSetCode=DCIS_POPRES1 (accessed on 03/04/2020), respectively.

https://www.ecdc.europa.eu/en/publications-data/download-todays-data-geographic-distribution-covid-19-cases-worldwide

https://www.gov.uk/government/publications/covid-19-track-coronavirus-cases

https://github.com/pcm-dpc/COVID-19

https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/datasets/populationestimatesforukenglandandwalesscotlandandnorthernireland

http://dati.istat.it/Index.aspx?DataSetCode=DCIS_POPRES1

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted April 17, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Global convergence of COVID-19 basic reproduction number and estimation from early-time SIR dynamics
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Global convergence of COVID-19 basic reproduction number and estimation from early-time SIR dynamics
Gabriel G. Katul, Assaad Mrad, Sara Bonetti, Gabriele Manoli, Anthony J. Parolari
medRxiv 2020.04.10.20060954; doi: https://doi.org/10.1101/2020.04.10.20060954
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Global convergence of COVID-19 basic reproduction number and estimation from early-time SIR dynamics
Gabriel G. Katul, Assaad Mrad, Sara Bonetti, Gabriele Manoli, Anthony J. Parolari
medRxiv 2020.04.10.20060954; doi: https://doi.org/10.1101/2020.04.10.20060954

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1747)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (653)
  • Epidemiology (10780)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2933)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1918)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12496)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (321)
  • Neurology (2780)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (554)
  • Occupational and Environmental Health (597)
  • Oncology (1454)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (379)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2630)
  • Public and Global Health (5338)
  • Radiology and Imaging (1002)
  • Rehabilitation Medicine and Physical Therapy (594)
  • Respiratory Medicine (722)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)